These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
144 related articles for article (PubMed ID: 11709418)
21. Effect of an ET(B)-selective and a mixed ET(A/B) endothelin receptor antagonist on venomotor tone in deoxycorticosterone-salt hypertension. Johnson RJ; Galligan JJ; Fink GD J Hypertens; 2001 Mar; 19(3):431-40. PubMed ID: 11288813 [TBL] [Abstract][Full Text] [Related]
22. Effects of endothelin on resistance arteries of DOCA-salt hypertensive rats. Deng LY; Schiffrin EL Am J Physiol; 1992 Jun; 262(6 Pt 2):H1782-7. PubMed ID: 1621836 [TBL] [Abstract][Full Text] [Related]
23. Xanthine oxidase and mitochondria contribute to vascular superoxide anion generation in DOCA-salt hypertensive rats. Viel EC; Benkirane K; Javeshghani D; Touyz RM; Schiffrin EL Am J Physiol Heart Circ Physiol; 2008 Jul; 295(1):H281-8. PubMed ID: 18487445 [TBL] [Abstract][Full Text] [Related]
24. Angiotensin II receptor blockade unmasks a depressor response to endothelin antagonists in rats. Richard V; Hogie M; Thuillez C Fundam Clin Pharmacol; 2000; 14(2):101-6. PubMed ID: 10796056 [TBL] [Abstract][Full Text] [Related]
25. Effect of vasopressin antagonism on structure and mechanics of small arteries and vascular expression of endothelin-1 in deoxycorticosterone acetate salt hypertensive rats. Intengan HD; He G; Schiffrin EL Hypertension; 1998 Oct; 32(4):770-7. PubMed ID: 9774378 [TBL] [Abstract][Full Text] [Related]
26. Endothelin-1 gene expression and vascular hypertrophy in DOCA-salt hypertension compared to spontaneously hypertensive rats. Schiffrin EL; Lariviere R; Li JS; Sventek P; Touyz RM Clin Exp Pharmacol Physiol Suppl; 1995 Dec; 22(1):S188-90. PubMed ID: 9072349 [TBL] [Abstract][Full Text] [Related]
28. Enhanced expression of the endothelin-1 gene in blood vessels of DOCA-salt hypertensive rats: correlation with vascular structure. Schiffrin EL; Larivière R; Li JS; Sventek P J Vasc Res; 1996; 33(3):235-48. PubMed ID: 8924521 [TBL] [Abstract][Full Text] [Related]
29. Magnesium supplementation and deoxycorticosterone acetate--salt hypertension: effect on arterial mechanical properties and on activity of endothelin-1. Berthon N; Laurant P; Hayoz D; Fellmann D; Brunner HR; Berthelot A Can J Physiol Pharmacol; 2002 Jun; 80(6):553-61. PubMed ID: 12117304 [TBL] [Abstract][Full Text] [Related]
30. Endothelin-1-induced contraction in isolated aortae from normotensive and DOCA-salt hypertensive rats: effect of magnesium. Laurant P; Berthelot A Br J Pharmacol; 1996 Dec; 119(7):1367-74. PubMed ID: 8968545 [TBL] [Abstract][Full Text] [Related]
31. Effect of chronic treatment with two different ET(A) selective endothelin receptor antagonists on blood pressure and small artery structure of deoxycorticosterone acetate (DOCA)-salt hypertensive rats. Li JS; Turgeon A; Schiffrin EL Am J Hypertens; 1998 May; 11(5):554-62. PubMed ID: 9633791 [TBL] [Abstract][Full Text] [Related]
32. Effects of endothelin on blood pressure and renal hemodynamics in DOCA-salt hypertensive rats under conscious and unrestrained condition. Yokokawa K; Kohno M; Murakawa K; Yasunari K; Inoue T; Takeda T Clin Exp Hypertens A; 1990; 12(6):1049-62. PubMed ID: 2245514 [TBL] [Abstract][Full Text] [Related]
34. Role of NO and angiotensin II in the early development of endothelial functions impairment and cardiac hypertrophy in deoxycorticosterone acetate-salt hypertension. K-Laflamme A; Oster L; Cardinal R; de Champlain J Can J Physiol Pharmacol; 1998 Jun; 76(6):665-75. PubMed ID: 9923405 [TBL] [Abstract][Full Text] [Related]